James Healy
Director at Natera; Director at Rapport Therapeutics; Director at Seaport Therapeutics. Based in Menlo Park, California.
- Rank
- 7042nd of 14,644
- Companies held
- 1
- Largest holding
- NTRA, 100.0% of total
- Latest SEC filing
- Oct 28, 2026
- Listed but not counted
- $597M
What the $13.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Natera NTRA Common Stock | Directly | 46,260 | $289.92 | $13.4M | 100.0% | Form 4, Apr 25, 2025 |
Share counts are the amounts James Healy reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on James Healy's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Natera NTRA Common Stock | Through Sofinnova Venture Partners IX, L.P. Held by a company or fund the insider manages | 1,550,280 | $289.92 | $449M | — | Form 4, Apr 25, 2025 |
| Rapport Therapeutics RAPP Common Stock | Through Sofinnova Venture Partners XI, L.P. Held by a company or fund the insider manages | 2,815,707 | $23.59 | $66.4M | — | Form 4, Oct 28, 2026 |
| Seaport Therapeutics SPTX Common Stock | Through Sofinnova Venture Partners XI, L.P. Held by a company or fund the insider manages | 2,731,538 | $18.32 | $50.0M | — | Form 4, May 4, 2026 |
| ArriVent BioPharma AVBP Common Stock | Sofinnova Venture Partners XI, L.P. Held by a company or fund the insider manages | 1,696,752 | $11.26 | $19.1M | — | Form 4, Jan 30, 2024 |
| BioAge Labs BIOA Common Stock | Sofinnova Venture Partners XI, L.P. Held by a company or fund the insider manages | 2,227,124 | $4.71 | $10.5M | — | Form 4, Sep 27, 2024 |
| Rapport Therapeutics RAPP Common Stock | Through SummitTX Pinnacle Master, L.P. - Healthcare 3 Held by a company or fund the insider manages | 25,267 | $23.59 | $596K | — | Form 4, Oct 28, 2026 |
| Rapport Therapeutics RAPP Common Stock | Through SummitTX Master, SPC -SummitTX Apex SP - Healthcare 3 Held by a company or fund the insider manages | 17,990 | $23.59 | $424K | — | Form 4, Oct 28, 2026 |
| Rapport Therapeutics RAPP Common Stock | Through SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3 Held by a company or fund the insider manages | 14,924 | $23.59 | $352K | — | Form 4, Oct 28, 2026 |
| BioAge Labs BIOA Common Stock | CRESTLINE SUMMIT PINNACLE MASTER, L.P. Held by a company or fund the insider manages | 26,497 | $4.71 | $125K | — | Form 4, Sep 27, 2024 |
| BioAge Labs BIOA Common Stock | Crestline Summit Master, SPC - PEAK SP Held by a company or fund the insider manages | 21,814 | $4.71 | $103K | — | Form 4, Sep 27, 2024 |
| BioAge Labs BIOA Common Stock | CRESTLINE SUMMIT MASTER, SPC - CRESTLINE SUMMIT APEX SP Held by a company or fund the insider manages | 18,353 | $4.71 | $86K | — | Form 4, Sep 27, 2024 |
| BioAge Labs BIOA Common Stock | Sofinnova Synergy Master Fund LP Held by a company or fund the insider manages | 11,113 | $4.71 | $52K | — | Form 4, Sep 27, 2024 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7039 | Timothy J. Bernlohr Director, Champion Homes | $13.4M |
| 7040 | Olafur S. Gudmundsson Director, JBT Marel. Chicago, IL | $13.4M |
| 7041 | Karen M. Dahut Executive Vice President, Booz Allen Hamilton Holding. San Diego, CA | $13.4M |
| 7042 | James Healy Director, Natera. Menlo Park, CA | $13.4M |
| 7043 | Sohail U. Ahmed Director, Lam Research. Fremont, CA | $13.4M |
| 7044 | Michael Heinrich Executive Chairman, ZeroStack. Dallas, TX | $13.4M |
| 7045 | Christopher L. Schremser Chief Technology Officer, Waystar Holding. Lehi, UT | $13.4M |
Other Natera insiders
All NTRA insiders- Matthew Rabinowitz$614MEXECUTIVE CHAIRMAN. #410 overall
- Roelof Botha$313MDirector. #400 overall
- Robert Alan Schueren$97.9MCHIEF OPERATING OFFICER. #1531 overall
- Jonathan Sheena$70.7MDirector. #1972 overall
- John Fesko$56.6MPRESIDENT, CHIEF BUS. OFFICER. #2319 overall
- Daniel Rabinowitz$48.7MSEC. AND CHIEF LEGAL OFFICER. #2594 overall
Questions
How much stock does James Healy own?
James Healy holds $13,411,699 in listed stock based on SEC filings and current prices, mostly Natera (NTRA). That ranks 7042nd on the Stock Rich List.
Is this James Healy's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did James Healy last buy or sell stock?
The most recent open-market trade on file is a purchase of 952,380 RAPP shares on Oct 28, 2026 at $21.00.